CDEK by Data4ThePeople

Sign in Sign up

← All organizations

FORMYCON AG

For profit

Also known as: Formycon AG | FORMYCON AG

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Dec 18, 2025

Timeline

1990s

Jun 1, 1999
FORMYCON AG— Founded

2020s

Dec 18, 2025
ranibizumab— Marketing Organization

Drugs by trial phase (2 distinct, 3 trials)

Phase 4 (1 own, 0 via acquisition)

ranibizumab

Phase 3 (1 own, 0 via acquisition)

pembrolizumab

Marketed drugs (1)

ranibizumab

Recent trials (3)

NCT06643117Lead sponsorPhase 3Oct 3, 2024
NCT06551064Lead sponsorPhase 1Jul 1, 2024
NCT06708624Lead sponsorPhase 4Jun 11, 2024

Details

Founded: Martinsried, DE Jun 1, 1999
Last known activity: Dec 18, 2025